JAG1 and breast cancer: Interestingly, both canonical and non-canonical NF-κB signaling pathways have been implicated to activate the juxtacrine Notch signaling pathway via elevating JAG1 expression, leading to an expansion of BCSC populations in breast cancer [66,67] (Figure 1d).